Abstract
Allergy and asthma are the diseases of multifactorial etiologies increasing dramatically all over the world. Numerous factors (e.g., aeroallergen, toxin, pathogen, food, chemical insect debris, and drugs) play a key role in the pathophysiology of allergy and asthma. Recent advances in the field of genetics have led to the identification of genetic factors which are involved not only in the pathogenesis of asthma and allergy but also significantly (60–70 %) contribute toward the interindividual variability to drug response and adverse drug reactions. There are several common categories of medications for treating asthma and allergy. Significant heterogeneity in the efficacy and adverse drug reactions of anti-allergic and anti-asthmatic drugs have been observed and efforts have been made to study the role of genetic determinants in the variable interindividual response to medication. Armed with the knowledge of a patient’s pharmacogenomic information, a clinician could predict the response to certain drugs and adverse drug reactions to improve the efficacy and tolerability of the therapeutic interventions.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- ABP:
-
Diamine oxidase
- ADAM-33:
-
A disintegrin and metalloproteinase domain-containing protein 33
- ADRB2:
-
Beta adrenergic receptors
- ADRB-2:
-
Beta-2 adrenergic receptor
- ADRs:
-
Adverse Drug Reactions
- ALOX5:
-
Arachidonate 5 lipoxygenase
- ATP:
-
Adenosine triphosphate
- BALF:
-
Bronchoalveolar lavage fluid
- cAMP:
-
Cyclic adenosine monophosphate
- CCL11:
-
Chemokine (C-C motif) ligand 11
- CD-14:
-
Cluster of differentiation 14 (CD14)
- CFTR:
-
Cystic fibrosis transmembrane conductance regulator
- CHRM2:
-
Cholinergic receptor muscarinic 2
- CLCA1:
-
Calcium-activated chloride channel regulator 1
- COX-2:
-
Cycloxygenase-2
- CRDCP15:
-
Caspase recruitment domain-containing protein 15
- CRHR1:
-
Corticotrophin-releasing hormone receptor 1
- CYF1P2:
-
Cytoplasmic FMR1-interacting protein
- CYP1A2:
-
Cytochrome P450 family 1 subfamily A, polypeptide 2
- CYP2E1:
-
Cytochrome P450 family 2 subfamily E, polypeptide 1
- CysLTR1:
-
Cysteinyl leukotriene receptor
- DEFB1:
-
Defensin beta 1
- DNA:
-
Deoxyribonucleic acid
- DPP10:
-
Dipeptidyl-peptidase 10
- FCER1B:
-
Fc epsilon receptor I beta-chain
- FDA:
-
Food and Drug Administration
- FKB51:
-
FK506-binding protein 51
- FLG:
-
Flaggrin
- GATA3:
-
Trans-acting T-Cell-specific transcription factor
- GC-R:
-
Glucocorticoid resistant
- GC-S:
-
Glucocorticoid sensitive
- GM-CSF:
-
Granulocyte-macrophage colony-stimulating factor
- GMCSF:
-
Granulocyte-monocyte colony-stimulating factor
- GPRA:
-
G protein-coupled receptor for asthma
- GSNOR:
-
S-Nitrosoglutathione reductase
- GST:
-
Glutathione S-transferase
- GWAS:
-
Genome-wide association study
- HDC:
-
Histidine decarboxylase
- hGR:
-
Human glucocorticoid receptor
- HLA:
-
Human leukocyte antigen
- HNM:
-
Histamine N-methyl transferase
- HRH:
-
Histamine receptor
- IFNG:
-
Interferon γ
- IFNGR1:
-
Interferon gamma receptor-1
- IgE:
-
Immunoglobulin E
- IL:
-
Interleukin
- IL-1β:
-
Interleukin-1β
- ISSAC:
-
The International Study of Asthma and Allergies in Childhood
- JAK1:
-
Janus kinase 1
- Km:
-
Michaelis-Menton Constant
- LABA:
-
Long-acting beta-2 agonists
- LT:
-
Leukotriene
- LTC4S:
-
Leukotriene C4 synthase
- mRNA:
-
Messenger ribonucleic acid
- NAD+ :
-
Nicotinamide adenine dinucleotide
- NF-κB:
-
Nuclear factor kappa B
- PARP-1:
-
Poly (ADP-ribose) polymerase 1
- PBMC:
-
Peripheral blood mononuclear cells
- PDE4D:
-
phosphodiesterase-4D
- PHF-11:
-
Plant homeodomain finger protein 11
- POSTN:
-
Periostin osteoblast-specific factor
- RNA:
-
Ribonucleic acid
- SABA:
-
Short-acting beta-2 agonists
- Serpin B2:
-
Serpin peptidase inhibitor clade B2
- SLE:
-
Systemic Lupus Erythematous
- SNPs:
-
Single nucleotide polymorphisms
- SPINK5:
-
Serine protease inhibitor kazal type 5
- STAT6:
-
Signal transducer and activator of transcription
- TBX2:
-
T-box transcription factor
- TCγ:
-
T cell antigen receptor γ chain
- TGF-β:
-
Transforming growth factor Β
- TH1:
-
T helper 1
- TH2:
-
T helper 2
- TLR:
-
Toll-like receptors
- TNF-α:
-
Tumor necrosis factor-α
- Vmax:
-
Maximum rate of the enzyme catalyzed reaction
References
Aksoy S, Raftogianis R, Weinshilboum R (1996) Human histamine N-methyltransferase gene: structural characterization and chromosomal location. Biochem Biophys Res Commun 219(2):548–554
Alkhatib HM, Chen DF, Cherney B, Bhatia K, Notario V, Giri C, Stein G, Slattery E, Roeder RG, Smulson ME (1987) Cloning and expression of cDNA for human poly(ADP-ribose) polymerase. Proc Natl Acad Sci USA 84:1224–1228
Allen M, Heinzmann A, Noguchi E, Abecasis G, Broxholme J, Ponting CP, Bhattacharyya S, Tinsley J, Zhang Y, Holt R, Jones EY, Lench N, Carey A, Jones H, Dickens NJ, Dimon C, Nicholls R, Baker C, Xue L, Townsend E, Kabesch M, Weiland SK, Carr D, von Mutius E, Adcock IM, Barnes PJ, Lathrop GM, Edwards M, Moffatt MF, Cookson WO (2003) Positional cloning of a novel gene influencing asthma from chromosome 2q14. Nat Genet 35(3):258–263
Asher MI, Montefort S, Björkstén B, Lai CK, Strachan DP, Weiland SK, Williams H, ISAAC Phase Three Study Group (2006) Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 368(9537):733–743
Ashutosh K (2000) Nitric oxide and asthma: a review. Curr Opin Pulm Med 6(1):21–25
Ayuso P, García-Martín E, Martínez C, Agúndez JA (2007) Genetic variability of human diamine oxidase: occurrence of three nonsynonymous polymorphisms and study of their effect on serum enzyme activity. Pharmacogenet Genomics 17(9):687–693
Balzar S, Strand M, Rhodes D, Wenzel SE (2007) IgE expression pattern in lung: relation to systemic IgE and asthma phenotypes. J Allergy Clin Immunol 119:855–862
Banerjee TR, Fitzmaurice GM, Kotlov TV, LaHive K, LeBoff MS, Israel E (2001) Effects of inhaled glucocorticoids on bone density in premenopausal women. N Engl J Med 345:941–947
Barnes PJ (2002) Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids. EurRespir J 19:182–191
Barnes PJ, Woolcock AJ (1998) Difficult asthma. Eur Respir J 12(5):1209–1218
Basehore MJ, Howard TD, Lange LA, Moore WC, Hawkins GA, Marshik PL, Harkins MS, Meyers DA, Bleecker ER (2004) A comprehensive evaluation of IL4 variants in ethnically diverse populations: association of total serum IgE levels and asthma in white subjects. J Allergy Clin Immunol 114(1):80–87
Begley S (2001) Made to order medicine. Newsweek 137(26):64–66, 68–9
Berce V, Potocnik U (2010) Association of Q551R polymorphism in the interleukin 4 receptor gene with nonatopic asthma in Slovenian children. Wien Klin Wochenschr 122(2):11–18
Bergeron C, Al-Ramli W, Hamid Q (2009) Remodeling in asthma. Proc Am Thorac Soc 6(3):301–305
Bergstrand H (1980) Phosphodiesterase inhibition and theophylline. Eur J Respir Dis Suppl 109:37–44
Bhatia K, Kang VH, Stein GS, Bustin M, Cherney BW, Notario V, Haque SJ, Huppi K, Smulson ME (1990) Cell cycle regulation of an exogenous human poly(ADP-ribose) polymerase cDNA introduced into murine cells. J Cell Physiol 144:345–353
Bleecker ER, Lawrance RM, Ambrose HJ, Goldman M (2008) Beta2- adrenergic receptor gene polymorphisms: is Arg/Arg genotype associated with serious adverse events during treatment with budesonide and formoterol in one pressurized metered dose inhaler. Am J RespirCrit Care Med 177:A775
Bloemen K, Verstraelen S, Van Den Heuvel R, Witters H, Nelissen I, Schoeters G (2007) The allergic cascade: review of the most important molecules in the asthmatic lung. Immunol Lett 113:6–18
Bottini N, Borgiani P, Otsu A, Saccucci P, Stefanini L, Greco E, Fontana L, Hopkin JM, Mao XQ, Shirakawa T (2002) IL-4 receptor alpha chain genetic polymorphism and total IgE levels in the English population: two-locus haplotypes are more informative than individual SNPs. Clin Genet 61:288–292
Boulares AH, Zoltoski AJ, Sherif ZA, Jolly P, Massaro D, Smulson ME (2003) Gene knockout or pharmacological inhibition of poly(ADP-ribose) polymerase-1 prevents lung inflammation in a murine model of asthma. Am J Respir Cell Mol Biol 28:322–329
Bousquet J (2000) Allergy as a global problem: think globally act globally. Allergy 57(8):661–662
Busse WW, Lemanske RF (2001) Asthma. N Engl J Med 344:350–362
Busse W, Corren J, Lanier BQ, McAlary M, Fowler-Taylor A, Cioppa GD, van As A, Gupta N (2001) Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol 108:184–190
Cao WH, Wang X, Frappart L, Rigal D, Wang ZQ, Shen Y, Tong WM (2007) Analysis of genetic variants of the poly(ADP-ribose) polymerase-1 gene in breast cancer in French patients. Mutat Res 632:20–28
Casale TB, Nelson HS, Stricker WE, Raff H, Newman KB (2001) Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients (see comments). Ann Allergy Asthma Immunol 87:379–385
Charmandari E, Kino T, Ichijo T, Jubiz W, Mejia L, Zachman K, Chrousos GP (2007) A novel point mutation in helix 11 of the ligand-binding domain of the human glucocorticoid receptor gene causing generalized glucocorticoid resistance. J Clin Endocrinol Metab 92(10):3986–3990
Chen GL, Zhu B, Nie WP, Xu ZH, Tan ZR, Zhou G, Liu J, Wang W, Zhou HH (2004) Single nucleotide polymorphisms and haplotypes of histamine N-methyltransferase in patients with gastric ulcer. Inflamm Res 53:484–488
Cherney BW, McBride OW, Chen DF, Alkhatib H, Bhatia K, Hensley P, Smulson ME (1987) cDNA sequence, protein structure, and chromosomal location of the human gene for poly(ADP-ribose) polymerase. Proc Natl Acad Sci USA 84:8370–8374
Cho SH (2010) Pharmacogenomics approaches to asthma treatment. Allergy Asthma Immunol Res 2(3):177–182
Choudhry S, Ung N, Avila PC, Ziv E, Nazario S, Casal J, Torres A, Gorman JD, Salari K, Rodriguez-Santana JR et al (2005) Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma. Am J Respir Crit Care Med 171:563–570
Choudhry S, Que LG, Yang Z, Liu L, Eng C, Kim SO et al (2010) GSNO reductase and beta2-adrenergic receptor gene-gene interaction: bronchodilator responsiveness to albuterol. Pharmacogenet Genomics 20(6):351–358
Cockcroft JR, Gazis AG, Cross DJ, Wheatley A, Dewar J, Hall IP, Noon JP (2006) Beta(2)-adrenoceptor polymorphism determines vascular reactivity in humans. Hypertension 36:371–375
Corry DB, Grunig G, Hadeiba H, Kurup VP, Warnock ML, Sheppard D, Rennick DM, Locksley RM (1998) Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice. Mol Med 4:344–355
Cosman D, Lyman SD, Idzerda RL, Beckmann MP, Park LS, Goodwin RG, March CJ (1990) A new cytokine receptor superfamily. Trends Biochem Sci 15:265–270
Cottet F, Blanche H, Verasdonck P, Le Gall I, Schachter F, Burkle A, Muiras ML (2000) New polymorphisms in the human poly(ADP-ribose) polymerase-1 coding sequence: lack of association with longevity or with increased cellular poly(ADP-ribosyl)ation capacity. J Mol Med (Berl) 78:431–440
Datta R, Naura AS, Zerfaoui M, Errami Y, Oumouna M, Kim H, Ju J, Ronchi VP, Haas AL, Boulares AH (2011) PARP-1 deficiency blocks IL-5 expression through calpain-dependent degradation of STAT-6 in a murine asthma model. Allergy 66:853–861
De Bosscher K, Vanden Berghe W, Haegeman G (2003) The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. Endocr Rev 24(4):488–522
Deindl P, Peri-Jerkan S, Deichmann K, Niggemann B, Lau S, Sommerfeld C, Sengler C, Müller S, Wahn U, Nickel R, Heinzmann A (2005) German Multicenter Atopy Study Group. No association of histamine- N-methyltransferase polymorphism with asthma or bronchial hyperresponsiveness in two German pediatric populations. Pediatr Allergy Immunol 16(1):40–42
Demoly P, Bousquet J (2001) Epidemiology of drug allergy. Curr Opin Allergy Clin Immunol 1:305–310
Di Blasio AM, van Rossum EF, Mastrini S et al (2003) The relation between two polymorphisms in the glucocorticoid receptor gene and body mass index, blood pressure and cholesterol in obese patients. Clin Endocrinol 59:68–74
Dishy V, Sofowora GG, Xie HG, Kim RB, Byrne DW, Stein CM, Wood AJ (2001) The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med 345:1030–1035
DiSilvestro RA, Jones AA, Smith D, Wildman R (1997) Plasma diamine oxidase activities in renal dialysis patients, a human with spontaneous copper deficiency and marginally copper deficient rats. Clin Biochem 30(7):559–563
Dolen WK (2004) Pharmacogenomics in clinical allergy. Allergy Clin Immunol Int J World Allergy Org 16:231–236
Donfack J, Kogut P, Forsythe S (2003) Sequence variation in the promoter region of the cholinergic receptor muscranic 3 gene and asthma and atopy. J Allergy Clin Immunol 111:527–532
Drazen JM, Yandava CN, Dubé L, Szczerback N, Hippensteel R, Pillari A, Israel E, Schork N, Silverman ES, Katz DA, Drajesk J (1999) Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment. Nat Genet 22(2):168–170
Elmer-Dewitt P (2001) The future of drugs. Time 157(2):56–57
Espinoza LA, Smulson ME, Chen Z (2007) Prolonged poly(ADP-ribose) polymerase-1 activity regulates JP-8-induced sustained cytokine expression in alveolar macrophages. Free Radic Biol Med 42:1430–1440
Europian Community Respiratory Health Survey (1996) Variations in the prevalence of respiratory symptoms, self-reported asthma attacks and use of asthma medication in the Europian Community Respiratory Health Survey. Eur Respir J 9:687–695
Evans WE, McLeod HL (2003) Pharmacogenomics – drug disposition, drug targets, and side effects. N Engl J Med 348:538–549
Fenech AG, Ellul-Micallef R (2005) Pharmacogenetics of asthma therapeutics. Br J Clin Pharmacol 9:24–28
Fu JJ, Baines KJ, Wood LG, Gibson PG (2013) Systemic inflammation is associated with differential gene expression and airway neutrophilia in asthma. OMICS 17(4):187–199
Funk CD, Hoshiko S, Matsumoto T, Radmark O, Samuelsson B (1989) Characterization of the human 5-lipoxygenase gene. Proc Natl Acad Sci USA 86:2587–2591
Garabrant DH, Schweitzer S (2002) Epidemiology of latex sensitisation and allergies in health care workers. J Allergy Clin Immunol 110:S82–S95
Garcia-Martin E, Garcia-Menaya J, Sanchez B, Martinez C, Rosendo R, Agundez JA (2007) Polymorphisms of histamine metabolizing enzymes and clinical manifestations of asthma and allergic rhinitis. Clin Exp Allergy 37(8):1175–1182
García-Martín E, Ayuso P, Martínez C, Blanca M, Agúndez JA (2009) Histone. Pharmacogenomics 10(5):867–883
Gell PGH, Coombs RRA (1963) Clinical aspects of immunology. Blackwell Ist ed, Oxford
Global Initiative for Asthma (GINA) (2006) Global strategy for asthma management and prevention. http://www.ginasthma.org
Gradwohl G, Menissier de Murcia JM, Molinete M, Simonin F, Koken M, Hoeijmakers JH, de Murcia G (1990) The second zinc-finger domain of poly(ADP-ribose) polymerase determines specificity for single-stranded breaks in DNA. Proc Natl Acad Sci USA 87:2990–2994
Green SA, Turki J, Innis M, Liggett SB (1994) Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 33:9414–9419
Hakonarson H, Bjornsdottir US, Halapi E, Bradfield J, Zink F, Mouy M, Helgadottir H, Gudmundsdottir AS, Andrason H, Adalsteinsdottir AE, Kristjansson K, Birkisson I, Arnason T, Andresdottir M, Gislason D, Gislason T, Gulcher JR, Stefansson K (2005) Profiling of genes expressed in peripheral blood mononuclear cells predicts glucocorticoid sensitivity in asthma patients. Proc Natl Acad Sci USA 102(41):14789–14794
Halapi E, Hakonarson H (2004) Recent development in genomic and proteomic research for asthma. Curr Opin Pulm Med 10(1):22–30
Haller G, Torgerson DG, Ober C, Thompson EE (2009) Sequencing the IL4 locus in African Americans implicates rare noncoding variants in asthma susceptibility. J Allergy Clin Immunol 124(6):1204–1209.e9
Hamid Q, Tulic M (2009) Immunobiology of asthma. Annu Rev Physiol 71:489–507
Hassa PO, Hottiger MO (2002) The functional role of poly(ADP-ribose)polymerase 1 as novel coactivator of NF-kappaB in inflammatory disorders. Cell Mol Life Sci 59:1534–1553
Hawkins GA, Lazarus R, Smith RS, Tantisira KG, Meyers DA, Peters SP, Weiss ST, Bleecker ER (2009) The glucocorticoid receptor heterocomplex gene STIP1 is associated with improved lung function in asthmatic subjects treated with inhaled corticosteroids. J Allergy Clin Immunol 123(6):1376–1383.e7
Hoffjan S, Nicolae D, Ober C (2003) Association studies for asthma and atopic diseases: a comprehensive review of the literature. Respir Res 4(1):14
Holgate ST (2008) Are long acting β2 agonists safe in the treatment of asthma. Pol Arch Med Wewn 118(9):460–461
Hong SJ, Kim HB, Kang MJ, Lee SY, Kim JH, Kim BS, Jang SO, Shin HD, Park CS (2007) TNF-alpha (−308 G/A) and CD14 (−159T/C) polymorphisms in the bronchial responsiveness of Korean children with asthma. J Allergy Clin Immunol 119:398–404
Howard TD, Koppelman GH, Xu J, Zheng SL, Postma DS, Meyers DA, Bleecker ER (2002) Gene-gene interaction in asthma: IL4RA and IL13 in a Dutch population with asthma. Am J Hum Genet 70(1):230–236
Huizenga NA, Koper JW, de Lange P, Pols HA, Stolk RP, Burger H, Grobbee DE, Brinkmann AO, de Jong FH, Lamberts SW (1998) A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab 83(1):144–151
Hurley DM, Accili D, Stratakis CA, Karl M, Vamvakopoulos N, Rorer E, Constantine K, Taylor SI, Chrousos GP (1991) Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance. J Clin Invest 87(2):680–686
Igaz P, Fitzimons CP, Szalai C, Falus A (2002) Histamine genomics in silico. Am J Pharmacogenomics 2(1):67–72
In KH, Asano K, Beier D, Grobholz J, Finn PW, Silverman EK, Silverman ES, Collins T, Fischer AR, Keith TP, Serino K, Kim SW, De Sanctis GT, Yandava C, Pillari A, Rubin P, Kemp J, Israel E, Busse W, Ledford D, Murray JJ, Segal A, Tinkleman D, Drazen JM (1997) Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription. J Clin Invest 99(5):1130–1137
International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee (1998) Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 351(9111):1225–1232
Isaksson M (2001) Skin reactions to inhaled corticosteroids. Drug Saf 24(5):369–373
Israel E, Drazen JM, Liggett SB, Boushey HA, Cherniack RM, Chinchilli VM, Cooper DM, Fahy JV, Fish JE, Ford JG, Kraft M, Kunselman S, Lazarus SC, Lemanske RF, Martin RJ, McLean DE, Peters SP, Silverman EK, Sorkness CA, Szefler SJ, Weiss ST, Yandava CN (2000) The effect of polymorphisms of the beta (2)-adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med 162:75–80
Ito K, Caramori G, Lim S, Oates T, Chung KF, Barnes PJ, Adcock IM (2002) Expression and activity of histone deacetylases in human asthmatic airways. Am J Respir Crit Care Med 166(3):392–396
Janson C, Anto J, Burney P, Chinn S, de Marco R, Heinrich J, Jarvis D, Kuenzli N, Leynaert B, Luczynska C, Neukirch F, Svanes C, Sunyer J, Wjst M, European Community Respiratory Health Survey II (2001) The European Community Respiratory Health Survey: What are the main results so far? European Community Respiratory Health Survey II. Eur Respir J 18:598–611
Jiang J, Zhang X, Yang H, Wang W (2009) Polymorphisms of DNA repair genes: ADPRT, XRCC1, and XPD and cancer risk in genetic epidemiology. Methods Mol Biol 471:305–333
John M, Au BT, Jose PJ, Lim S, Saunders M, Barnes PJ, Mitchell JA, Belvisi MG, Chung KF (1998) Expression and release of interleukin-8 by human airway smooth muscle cells: inhibition by Th-2 cytokines and corticosteroids. Am J Respir Cell Mol Biol 18(1):84–90
Joos L, Sandford AJ (2002) Genotype predictors of response to asthma medications. Curr Opin Pulm Med 8(1):9–15
Kabesch M (2005) Candidate gene association studies and evidence for gene-by-gene interactions. Immunol Allergy Clin North Am 25(4):681–708
Kabesch M, Schedel M, Carr D, Woitsch B, Fritzsch C, Weiland SK, von Mutius E (2006) IL-4/IL-13 pathway genetics strongly influence serum IgE levels and childhood asthma. J Allergy Clin Immunol 117(2):269–274
Kabesch M, Michel S, Tost J (2010) Epigenetic mechanisms and the relationship to childhood asthma. Eur Respir J 36(4):950–961
Kavuru M, Melamed J, Gross G, Laforce C, House K, Prillaman B, Baitinger L, Woodring A, Shah T (2000) Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 105:1108–1116
Kedda MA, Lose F, Duffy D, Bell E, ThompsonPJ UJ (2005) The CD14 C-159T polymorphism is not associated with asthma or asthma severity in an Australian adult population. Thorax 60:211–214
Keller MB, Lowenstein SR (2002) Epidemiology of asthma. Semin Respir Crit Care Med 23(4):317–329
Kidwell WR, Mage MG (1976) Changes in poly(adenosine diphosphate-ribose) and poly(adenosine diphosphate-ribose) polymerase in synchronous HeLa cells. Biochemistry 15:1213–1217
Kim SH, Ye YM, Hur GY, Lee SK, Sampson AP, Lee HY, Park HS (2007) CysLTR1 promoter polymorphism and requirement for leukotriene receptor antagonist in aspirin-intolerant asthma patients. Pharmacogenomics 8:1143–1150
Kips JC, Brusselle GG, Joos GF, Peleman RA, Devos RR, Tavernier JH, Pauwels RA (1995) Importance of interleukin-4 and interleukin-12 in allergen-induced airway changes in mice. Int Arch Allergy Immunol 107:115–118
Klotsman M, York TP, Pillai SG, Vargas-Irwin C, Sharma SS, van den Oord EJ, Anderson WH (2007) Pharmacogenetics of the 5-lipoxygenase biosynthetic pathway and variable clinical response to montelukast. Pharmacogenet Genomics 17(3):189–196
Kondo M, Takeshita T, Ishii N, Nakamura M, Watanabe S, Arai K, Sugamura K (1993) Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. Science 262:1874–1877
Koster ES, Maitland-van der Zee AH, Tavendale R, Mukhopadhyay S, Vijverberg SJ, Raaijmakers JA, Palmer CN (2011) FCER2 T2206C variant associated with chronic symptoms and exacerbations in steroid-treated asthmatic children. Allergy 66(12):1546–1552
Kumari K, Rana AC (2012) A review on epidemiology, pathophysiology and management of Asthma. J Appl Pharm Sci 2(7):55–64
Laitinen T, Polvi A, Rydman P, Vendelin J, Pulkkinen V, Salmikangas P, Mäkelä S, Rehn M, Pirskanen A, Rautanen A, Zucchelli M, Gullstén H, Leino M, Alenius H, Petays T, Haahtela T, Laitinen T, Polvi A, Rydman P, Vendelin J, Pulkkinen V, Salmikangas P, Mäkelä S, Rehn M, Pirskanen A, Rautanen A, Zucchelli M, Gullstén H, Leino M, Alenius H, Petäys T, Haahtela T, Laitinen A, Laprise C, Hudson TJ, Laitinen LA, Kere J (2004) Characterization of a common susceptibility locus for asthma-related traits. Science 304(5668):300–304
Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J et al (2001) Initial sequencing and analysis of the human genome. Nature 409:860–921
Lee SG, Kim BS, Kim JH, Lee SY, Choi SO, Shim JY, Hong TJ, Hong SJ (2004) Gene-gene interaction between interleukin-4 and interleukin-4 receptor alpha in Korean children with asthma. Clin Exp Allergy 34:1202–1208
Leigh R, Ellis R, Wattie JN, Hirota JA, Matthaei KI, Foster PS, O’Byrne PM, Inman MD (2004) Type 2 cytokines in the pathogenesis of sustained airway dysfunction and airway remodeling in mice. Am J Respir Crit Care Med 169:860–867
LeVan TD, Von Essen S, Romberger DJ, Lambert GP, Martinez FD, Vasquez MM, Merchant JA (2005) Polymorphisms in the CD14 gene associated with pulmonary function in farmers. Am J Respir Crit Care Med 171:773–779
Levy H, Raby BA, Lake S, Tantisira KG, Kwiatkowski D, Lazarus R, Silverman EK, Richter B, Klimecki WT, Vercelli D, Martinez FD, Weiss ST (2005) Association of defensin beta-1 gene polymorphisms with asthma. J Allergy Clin Immunol 115(2):252–258
Liggett SB (1995) Genetics of beta 2-adrenergic receptor variants in asthma. Clin Exp Allergy 25(2):89–94, discussion 95–86
Liggett SB (2000) The pharmacogenetics of beta2-adrenergic receptors: relevance to asthma. J Allergy Clin Immunol 105:S487–S492
Lima JJ, Thomason DB, Mohamed MH, Eberle LV, Self TH, Johnson JA (1999) Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics. Clin Pharmacol Ther 65:519–525
Lima JJ, Zhang S, Grant A, Shao L, Tantisira KG, Allayee H, Wang J, Sylvester J, Holbrook J, Wise R, Weiss ST, Barnes K (2006) Influence of leukotriene pathway polymorphisms on response to montelukast in asthma. Am J Respir Crit Care Med 173(4):379–385
Lipworth B, Koppelman GH, Wheatley AP, KeJeune I, Coutie W, Meurs H, Kauffman HF, Postma DS, Hall IP (2002) Beta-2 adrenoceptor promoter polymorphisms: Extended and functional effects in peripheral blood mononuclear cells. Thorax 57(1):61–66
Lis G, Kostyk E, Sanak M, Pietrzyk JJ (2001) Molecular studies in a population of children with bronchial asthma. Polymorphism in the promotor region of gene CD14. Pneumonol Alergol Pol 69:265–272
Litonjua AA, Gong L, Duan QL, Shin J, Moore MJ, Weiss ST, Johnson JA, Klein TE, Altman RB (2010) Very important pharmacogene summary ADRB2. Pharmacogenet Genomics 20(1):64–69
Lockett KL, Hall MC, Xu J, Zheng SL, Berwick M, Chuang SC, Clark PE, Cramer SD, Lohman K, Hu JJ (2004) The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function. Cancer Res 64:6344–6348
Loza MJ, Chang BL (2007) Association between Q551R IL4R genetic variants and atopic asthma risk demonstrated by meta-analysis. J Allergy Clin Immunol 120:578–585
Malmstorm K, Rodriguez-Gomez G, Guerra J, Villaran C, Pineiro A, Wei LX, Seidenberg BC, Reiss TF (1999) Oral montelukast, inhaled beclomethasone and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group. Ann Intern Med 130:487–495
March ME, Sleiman PM, Hakonarson H (2011) The genetics of asthma and allergic disorders. Discov Med 11(56):35–45
Marshall GD (2004) Internal and external environmental influences in allergic diseases. J Am Osteopath Assoc 104(5):S1–S6
Martinez FD (2005) Gene-environment interactions in asthma and allergies: a new paradigm to understand disease causation. Immunol Allergy Clin North Am 25:709–721
Martinez FD, Graves PE, Baldini M, Solomon S, Erickson R (1997) Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 100(12):3184–3188
Masoli M, Fabian D, Holt S, Beasley R (2004) Global Initiative for Asthma (GINA) Program2004The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 59(5):469–478
Matheson MC, Ellis JA, Raven J, Johns DP, Walters EH, Abramson MJ (2006) Beta2-adrenergic receptor polymorphisms are associated with asthma and COPD in adults. J Hum Genet 51:943–951
Maxwell TJ, Ameyaw MM, Pritchard S, Thornton N, Folayan G, Githang’a J, Indalo A, Tariq M, Mobarek A, Evans DA, Ofori-Adjei D, Templeton AR, McLeod HL (2005) Beta-2 adrenergic receptor genotypes and haplotypes in different ethnic groups. Int J Mol Med 16:573–580
Menissier-de Murcia J, Molinete M, Gradwohl G, Simonin F, de Murcia G (1989) Zinc-binding domain of poly(ADP-ribose) polymerase participates in the recognition of single strand breaks on DNA. J Mol Biol 210:229–233
Moffatt MF, Kabesch M, Liang L, Dixon AL, Strachan D, Heath S, Depner M, von Berg A, Bufe A, Rietschel E, Heinzmann A, Simma B, Frischer T, Willis-Owen SA, Wong KC, Illig T, Vogelberg C, Weiland SK, von Mutius E, Abecasis GR, Farrall M, Gut IG, Lathrop GM, Cookson WO (2007) Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 448(7152):470–473
Morrow TJ (2007) Implications of pharmacogenomics in the current and future treatment of asthma. J Manag Care Pharm 13(6):497–505
Munthe-Kaas MC, Carlsen KH, Håland G, Devulapalli CS, Gervin K, Egeland T, Carlsen KL, Undlien D (2008) T cell-specific T-box transcription factor haplotype is associated with allergic asthma in children. J Allergy Clin Immunol 121(1):51–56
NAEPP (National Asthma Education and Prevention Program) (2007) Full report of the Expert Panel: guidelines for the diagnosis and management of asthma (EPR-3). National Heart, Lung, and Blood Institute
Naseer T, Minshall EM, Leung DY, Laberge S, Ernst P, Martin RJ, Hamid Q (1997) Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am J Respir Crit Care Med 155(3):845–851
Naura AS, Hans CP, Zerfaoui M, You D, Cormier SA, Oumouna M, Boulares AH (2008) Post-allergen challenge inhibition of poly(ADP-ribose) polymerase harbors therapeutic potential for treatment of allergic airway inflammation. Clin Exp Allergy 38:839–846
Nicolae D, Cox NJ, Lester LA, Schneider D, Tan Z, Billstrand C, Kuldanek S, Donfack J, Kogut P, Patel NM, Goodenbour J, Howard T, Wolf R, Koppelman GH, White SR, Parry R, Postma DS, Meyers D, Bleecker ER, Hunt JS, Solway J, Ober C (2005) Fine mapping and positional candidate studies identify HLA-G as an asthma susceptibility gene on chromosome 6p21. Am J Hum Genet 76(2):349–357
Noguchi E, Yokouchi Y, Zhang J, Shibuya K, Shibuya A, Bannai M, Tokunaga K, Doi H, Tamari M, Shimizu M, Shirakawa T, Shibasaki M, Ichikawa K, Arinami T (2005) Positional identification of an asthma susceptibility gene on human chromosome 5q33. Am J Respir Crit Care Med 172(2):183–188
Obase Y, Shimoda T, Kawano T, Saeki S, Tomari SY, Mitsuta-Izaki K, Matsuse H, Kinoshita M, Kohno S (2003) Polymorphisms in the CYP1A2 gene and theophylline metabolism in patients with asthma. Clin Pharmacol Ther 73:468–474
Ober C, Cox NJ, Abney M, Di Rienzo A, Lander ES, Changyaleket B, Gidley H, Kurtz B, Lee J, Nance M et al (1998) Genome-wide search for asthma susceptibility loci in a founder population. The collaborative study on the genetics of asthma. Hum Mol Genet 7:1393–1398
Oumouna M, Datta R, Oumouna-Benachour K, Suzuki Y, Hans C, Matthews K, Fallon K, Boulares H (2006) Poly(ADP-ribose) polymerase-1 inhibition prevents eosinophil recruitment by modulating Th2 cytokines in a murine model of allergic airway inflammation: a potential specific effect on IL-5. J Immunol 177:6489–6496
Palmer CN, Ismail T, Lee SP, Terron-Kwiatkowski A, Zhao Y, Liao H, Smith FJ, McLean WH, Mukhopadhyay S (2007) Filaggrin null mutations are associated with increased asthma severity in children and young adults. J Allergy Clin Immunol 120(1):64–68
Palmqvist M, Arvidsson P, Beckman O, Peterson S, Lotvall J (2001) Onset of bronchodilation of budesonide/formoterol vs. salmeterol/fluticasone in single inhalers. Pulm Pharmacol Ther 14:29–34
Paltiel AD, Fuhlbrigge AL, Kitch BT, Liljas B, Weiss ST, Neumann PJ, Kuntz KM (2001) Cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: results from the asthma policy model. J Allergy Clin Immunol 108:39–49
Papadopoulou N, Kalogeromitros D, Staurianeas NG, Tiblalexi D, Theoharides TC (2005) Corticotropin-releasing hormone receptor-1 and histidine decarboxylase expression in chronic urticaria. J Invest Dermatol 125(5):952–955
Patel L, Wales JK, Kibirige MS, Massarano AA, Couriel JM, Clayton PE (2001) Symptomatic adrenal insufficiency during inhaled corticosteroid treatment. Arch Dis Child 85:330–334
Patuzzo C, Trabetti E, Malerba G, Martinati LC, Boner AL, Pescollderungg L, Zanoni G, Pignatti PF (2000) No linkage or association of the IL-4Ralpha gene Q576R mutation with atopic asthma in Italian families. J Med Genet 37:382–384
Pearce N, Beasley R, Crane J, Burgess C, Jackson R (1995) End of the New Zealand asthma mortality epidemic. Lancet 345:41–44
Peng X, Yan H, You Z, Wang P, Wang S (2004) Effects of enteral supplementation with glutamine granules on intestinal mucosal barrier function in severe burned patients. Burns 30(2):135–139
Perin P, Berce V, Potocnik U (2011) CD14 gene polymorphism is not associated with asthma but rather with bronchial obstruction and hyperactivity in Slovenian children with non-atopic asthma. Respir Med 105(1):S54–S59
Pignatti PF (2004) Trends in pharmacogenomics of drugs used in the treatment of asthma. Pharmacol Res 49:343–349
Polson JB, Krzanowski JJ, Goldman AL, Szentivanyi A (1978) Inhibition of human pulmonary phosphodiesterase activity by therapeutic levels of theophylline. Clin Exp Pharmacol Physiol 5(5):535–539
Potaczek DP, Nishiyama C, Sanak M, Szczeklik A, Okumura K (2009) Genetic variability of the high-affinity IgE receptor alpha-subunit (Fc epsilon RI alpha). Immunol Res 45(1):75–84
Potter PC, Van Wyk L, Martin M, Lentes KU, Dowdle EB (1993) Genetic polymorphism of the beta-2 adrenergic receptor in atopic and non-atopic subjects. Clin Exp Allergy 23(10):874–877
Preuss CV, Wood TC, Szumlanski CL, Raftogianis RB, Otterness DM, Girard B, Scott MC, Weinshilboum RM (1998) Human histamine N-methyltransferase pharmacogenetics: common genetic polymorphisms that alter activity. Mol Pharmacol 53(4):708–717
Pykalainen M, Kinos R, Valkonen S, Rydman P, Kilpeläinen M, Laitinen LA, Karjalainen J, Nieminen M, Hurme M, Kere J, Laitinen T, Lahesmaa R (2005) Association analysis of common variants of STAT6, GATA3, and STAT4 to asthma and high serum IgE phenotypes. J Allergy Clin Immunol 115(1):80–87
Que LG, Yang Z, Stamler JS, Lugogo NL, Kraft M (2009) S-nitrosoglutathione reductase: an important regulator in human asthma. Am J Respir Crit Care Med 180:226–231
Raby BA, Van Steen K, Lazarus R, Celedon JC, Silverman EK, Weiss ST (2006) Eotaxin polymorphisms and serum total IgE levels in children with asthma. J Allergy Clin Immunol 117:298–305
Randolph AG, Lange C, Silverman EK, Lazarus R, Silverman ES, Raby B, Brown A, Ozonoff A, Richter B, Weiss ST (2004) The IL12B gene is associated with asthma. Am J Hum Genet 75(4):709–715
Redington AE, Meng QH, Springall DR, Evans TJ, Créminon C, Maclouf J, Holgate ST, Howarth PH, Polak JM (2001) Increased expression of inducible nitric oxide synthase and cyclo-oxygenase-2 in the airway epithelium of asthmatic subjects and regulation by corticosteroid treatment. Thorax 56(5):351–357
Regueiro V, Campos MA, Morey P, Sauleda J, Agusti AG, Garmendia J, Bengoechea JA (2009) Lipopolysaccharide-binding protein and CD14 are increased in the bronchoalveolar lavage fluid of smokers. Eur Respir J 33:273–281
Reihsaus E, Innis M, MacIntyre N, Liggett SB (1993) Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 8:334–339
Renauld JC (2001) New insights into the role of cytokines in asthma. J Clin Pathol 54:577–589
Revollo JR, Cidlowski JA (2009) Mechanisms generating diversity in glucocorticoid receptor signaling. Ann N Y Acad Sci 1179:167–178
Saleh D, Ernst P, Lim S, Barnes PJ, Giaid A (1998) Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid. FASEB J 12(11):929–937
Sampson AP, Siddiqui S, Buchanan D, Howarth PH, Holgate ST, Holloway JW, Sayers I (2000) Variant LTC(4) synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast. Thorax 55:S28–S31
Sayers I, Barton S, Rorke S, Beghé B, Hayward B, Van Eerdewegh P, Keith T, Clough JB, Ye S, Holloway JW, Sampson AP, Holgate ST (2003) Allelic association and functional studies of promoter polymorphism in the leukotriene C4 synthase gene (LTC4S) in asthma. Thorax 58:417–424
Schmidt D, Dent G, Rabe KF (1999) Selective phosphodiesterase inhibitors for the treatment of bronchial asthma and chronic obstructive pulmonary disease. Clin Exp Allergy 29(2):99–109
Schreiber V, Dantzer F, Ame JC, de Murcia G (2006) Poly(ADP-ribose): novel functions for an old molecule. Nat Rev Mol Cell Biol 7:517–528
Scott MG, Swan C, Wheatley AP, Hall IP (1999) Identification of novel polymorphisms within the promoter region of the human beta2 adrenergic receptor gene. Br J Pharmacol 126:841–844
Sharek PJ, Bergman DA (2000) The effect of inhaled steroids on the linear growth of children with asthma: a meta-analysis. Pediatrics 106:E8
Sharma S, Mann D, Singh TP, Ghosh B (2005) Lack of association of histamine-N-methyltransferase (HNMT) polymorphisms with asthma in the Indian population. J Hum Genet 50(12):611–617
Sheikh A, Alves B (2000) Hospital admissions for anaphylaxis: time trend study. BMJ 320:1441
Sherrid P (2001) Designer drugs: what’s best for patients isn’t always what’s best for profits. US News World Rep 131:30–32
Silverman ES, Liggett SB, Gelfand EW, Rosenwasser LJ, Baron RM, Bolk S, Weiss ST, Drazen JM (2001) The pharmacogenetics of asthma: a candidate gene approach. Pharmacogenomics J 1(1):27–37
Silverman ES, Hjoberg J, Palmer LJ, Tantisira KG, Weiss ST, Drazen JM (2003) Application of pharmacogenetics to the therapeutics of asthma. In: Huston D (ed) Therapeutic targets of airway inflammation. Marcel Dekker, New York, pp 823–838
Simbulan-Rosenthal CM, Rosenthal DS, Luo R, Samara R, Espinoza LA, Hassa PO, Hottiger MO, Smulson ME (2003) PARP-1 binds E2F-1 independently of its DNA binding and catalytic domains, and acts as a novel coactivator of E2F-1-mediated transcription during re-entry of quiescent cells into S phase. Oncogene 22:8460–8471
Singh AB, Kumar P (2003) Aeroallergens in clinical practice of allergy in India. An overview. Ann Agric Environ Med 10:131–136
Slager RE, Otulana BA, Hawkins GA, Yen YP, Peters SP, Wenzel SE, Meyers DA, Bleecker ER (2012) IL-4 receptor polymorphisms predict reduction in asthma exacerbations during response to an anti-IL-4 receptor alpha antagonist. J Allergy Clin Immunol 130(516–522):e514
Song CH, Tian X, Gelehrter TD (1999) Glucocorticoid receptor inhibits transforming growth factor- beta signaling by directly targeting the transcriptional activation function of Smad3. Proc Natl Acad Sci U S A 96(21):11776–11781
Stein J, Scheuermann EH, Yazdi R, Lembcke B, Caspary WF (1994) Reduced post heparin plasma diamine oxidase activity in patients with chronic renal failure. Z Gastroenterol 32(4):236–239
Suttner K, Rosenstiel P, Depner M, Schedel M, Pinto LA, Ruether A, Adamski J, Klopp N, Illig T, Vogelberg C, Schreiber S, von Mutius E, Kabesch M (2009) TBX21 gene variants increase childhood asthma risk in combination with HLX1 variants. J Allergy Clin Immunol 123(5):1062–1068, 1068.e1-8
Szalai C, Buzas EI, Fulop AK, Kohidai L, Falus A (2006) Genetic strategies in pharmacology of asthma and autoimmunity. Anti-Inflamm Anti-Allergic Agents Med Chem 5:383–399
Szefler SJ, Leung DY (1997) Glucocorticoid-resistant asthma: pathogenesis and clinical implications for management. Eur Respir J 10(7):1640–1647
Tam EK, Jourdan-LeSaux C, Stauder S, Bollt O, Reber B, Yamamoto F, Haymer D (2003) Polymorphisms in the interleukin-4 receptor alpha chain: association with traits of allergy and asthma in an admixed population in Hawaii. Cell Mol Biol (Noisy-le-Grand) 49:1345–1349
Tan S, Hall IP, Dewar J, Dow E, Lipworth B (1997) Association between beta 2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics. Lancet 350:995–999
Tantisira KG, Hwang ES, Raby BA (2004a) TBX21: a functional variant predicts improvement in asthma with the use of inhaled corticosteroids. Proc Natl Acad Sci 101:18099–18104
Tantisira KG, Lake S, Silverman E (2004b) Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids. Hum Mol Genet 13:1353–1359
Tantisira KG, Silverman ES, Mariani TJ, Xu J, Richter BG, Klanderman BJ (2007) FCER2: a pharmacogenetic basis for severe exacerbations in children with asthma. J Allergy Clin Immunol 120:1285–1291
Tantisira KG, Lazarus R, Litonjua AA, Klanderman B, Weiss ST (2008) Chromosome 17: association of a large inversion polymorphism with corticosteroid response in asthma. Pharmacogenet Genomics 18(8):733–737
Taylor DR, Drazen JM, Herbison GP, Yandava CN, Hancox RJ, Town GI (2000) Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism. Thorax 55:762–767
Tezcan G, Gurel CB, Tutluoglu B, Onaran I, Kanigur-Sultuybek G (2009) The Ala allele at Val762Ala polymorphism in poly(ADP-ribose) polymerase-1 (PARP-1) gene is associated with a decreased risk of asthma in a Turkish population. J Asthma 46:371–374
Thomsen M, Nordestgaard BG, Sethi AA, Tybjaerg-Hansen A, Dahl M (2012) Beta2-adrenergic receptor polymorphisms, asthma and COPD: two large population-based studies. Eur Respir J 39:558–566
Tse SM, Tantisira K, Weiss ST (2011) The pharmacogenetics and pharmacogenomics of asthma therapy. Pharmacogenomics J 11(6):383–392
Van Eerdewegh P, Little RD, Dupuis J, Del Mastro RG, Falls K, Simon J, Torrey D, Pandit S, McKenny J, Braunschweiger K, Walsh A, Liu Z, Hayward B, Folz C, Manning SP, Bawa A, Saracino L, Thackston M, Benchekroun Y, Capparell N, Wang M, Adair R, Feng Y, Dubois J, FitzGerald MG, Huang H, Gibson R, Allen KM, Pedan A, Danzig MR, Umland SP, Egan RW, Cuss FM, Rorke S, Clough JB, Holloway JW, Holgate ST, Keith TP (2002) Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 418(6896):426–430
Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG et al (2001) Thesequence of the human genome. Science 291:1304–1351
Vercelli D (2008) Discovering susceptibility genes for asthma and allergy. Nat Rev Immunol 8(3):169–182
Vladich FD, Brazille SM, Stern D, Peck ML, Ghittoni R, Vercelli D (2005) IL-13 R130Q, a common variant associated with allergy and asthma, enhances effector mechanisms essential for human allergic inflammation. J Clin Invest 115(3):747–754
Walsh KM, Bracken MB, Murk WK, Hoh J, Dewan AT (2010) Association between reduced copy-number at T-cell receptor gamma (TCRgamma) and childhood allergic asthma: a possible role for somatic mosaicism. Mutat Res 690(1–2):89–94
Wang Z, Chen C, Niu T, Wu D, Yang J, Wang B, Fang Z, Yandava CN, Drazen JM, Weiss ST et al (2001) Association of asthma with beta(2)-adrenergic receptor gene polymorphism and cigarette smoking. Am J Respir Crit Care Med 163:1404–1409
Wang L, Thomae B, Eckloff B, Wieben E, Weinshilboum R (2002) Human histamine N-methyltransferase pharmacogenetics: gene resequencing, promoter characterization, and functional studies of a common 5′-flanking region single nucleotide polymorphism (SNP). Biochem Pharmacol 64(4):699–710
Wang XG, Wang ZQ, Tong WM, Shen Y (2007) PARP1 Val762Ala polymorphism reduces enzymatic activity. Biochem Biophys Res Commun 354:122–126
Wechsler ME, Lehman E, Lazarus SC, Lemanske RF Jr, Boushey HA, Deykin A, Fahy JV, Sorkness CA, Chinchilli VM, Craig TJ, DiMango E, Kraft M, Leone F, Martin RJ, Peters SP, Szefler SJ, Liu W, Israel E, National Heart, Lung, and Blood Institute’s Asthma Clinical Research Network (2006) beta-Adrenergic receptor polymorphisms and response to salmeterol. Am J Respir Crit Care Med 173:519–526
Weinshilboum R (2003) Inheritance and drug response. N Engl J Med 348(6):529–537
Weiss ST, Lake SL, Silverman ES et al (2004) Asthma steroid pharmacogenetics: a study strategy to identify replicated treatment responses. Proc Am Thorac Soc 1:364–367
Weiss ST, Litonjua AA, Lange C, Lazarus R, Ligett SB, Bleecker ER, Tantisira KG (2006) Overview of pharmacogenetics of asthma. Pharmacogenomics J 6:311–326
Wenzel SE, Balzar S, Ampleford E, Hawkins GA, Busse WW, Calhoun WJ, Castro M, Chung KF, Erzurum S, Gaston B et al (2007) IL4R alpha mutations are associated with asthma exacerbations and mast cell/IgE expression. Am J Respir Crit Care Med 175:570–576
Whalen EJ, Foster MW, Matsumoto A, Ozawa K, Violin JD, Que LG, Nelson CD, Benhar M, Keys JR, Rockman HA et al (2007) Regulation of beta-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2. Cell 129:511–522
Woodruff PG, Boushey HA, Dolganov GM, Barker CS, Yang YH, Donnelly S, Ellwanger A, Sidhu SS, Dao-Pick TP, Pantoja C, Erle DJ, Yamamoto KR, Fahy JV (2007) Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc Natl Acad Sci USA 104(40):15858–15863
Wu X, Li Y, Chen Q, Chen F, Cai P, Wang L, Hu L (2010) Association and gene-gene interactions of eight common single-nucleotide polymorphisms with pediatric asthma in middle china. J Asthma 47(3):238–244
Yadollahi-Farsani M, Kefalas P, Saxty BA, MacDermot J (1999) Polymorphic forms of human ADP-ribosyltransferase-1 differences in their catalytic activities revealed by labeling of membrane-associated substrates. Eur J Biochem 262:342–348
Yan L, Galinsky RE, Bernstein JA, Liggett SB, Weinshilboum RM (2000) Histamine N-methyltransferase pharmacogenetics: association of a common functional polymorphism with asthma. Pharmacogenetics 10(3):261–266
Yelensky R, Li Y, Lewitzky S, Leroy E, Hurwitz C, Rodman D, Trifilieff A, Paulding CA (2012) A pharmacogenetic study of ADRB2 polymorphisms and indacaterol response in COPD patients. Pharmacogenomics J 12(6):484–488
Zetterstrom O, Buhl R, Mellem H, Perpiñá M, Hedman J, O’Neill S, Ekström T (2001) Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone. Eur Respir Dis 18(2):262–268
Zhang Y, Leaves NI, Anderson GG, Ponting CP, Broxholme J, Holt R, Edser P, Bhattacharyya S, Dunham A, Adcock IM, Pulleyn L, Barnes PJ, Harper JI, Abecasis G, Cardon L, White M, Burton J, Matthews L, Mott R, Ross M, Cox R, Moffatt MF, Cookson WO (2003) Positional cloning of a quantitative trait locus on chromosome 13q14 that influences immunoglobulin E levels and asthma. Nat Genet 34(2):181–186
Zhang AM, Li HL, Hao P, Chen YH, Li JH, Mo YX, Dai M (2006) Association of Q576R polymorphism in the interleukin-4 receptor gene with serum IgE levels in children with asthma. Zhongguo Dang Dai Er Ke Za Zhi 8:109–112
Zhang W, Zhang X, Qiu D, Sandford A, Tan WC (2007) IL-4 receptor genetic polymorphisms and asthma in Asian populations. Respir Med 101:186–190
Zhou H, Hong X, Jiang S, Dong H, Xu X, Xu X (2009a) Analyses of associations between three positionally cloned asthma candidate genes and asthma or asthma-related phenotypes in a Chinese population. BMC Med Genet 10:123
Zhou H, Alexis NE, Almond M, Donohue J, LaForce C, Bromberg PA, Peden DB (2009b) Influence of C-159T SNP of the CD14 gene promoter on lung function in smokers. Respir Med 103:1358–1365
Zock JP, Heinrich J, Jarvis D, Verlato G, Norbäck D, Plana E, Sunyer J, Chinn S, Olivieri M, Soon A, Villani S, Ponzio M, Dahlman-Hoglund A, Svanes C, Luczynska C, Indoor Working Group of the European Community Respiratory Health Survey II (2006) Distribution and determinants of house dust mite allergens in Europe: the European Community Respiratory Health Survey II. J Allergy Clin Immunol 118:682–690
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer India
About this chapter
Cite this chapter
Munshi, A., Crotti, L.B., Sharma, V., Sharma, S., Espinoza, L.A. (2013). Pharmacogenomics of Allergy and Asthma. In: Barh, D., Dhawan, D., Ganguly, N. (eds) Omics for Personalized Medicine. Springer, New Delhi. https://doi.org/10.1007/978-81-322-1184-6_24
Download citation
DOI: https://doi.org/10.1007/978-81-322-1184-6_24
Published:
Publisher Name: Springer, New Delhi
Print ISBN: 978-81-322-1183-9
Online ISBN: 978-81-322-1184-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)